Holly Martin

1.3k total citations
30 papers, 969 citations indexed

About

Holly Martin is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Holly Martin has authored 30 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Holly Martin's work include Mast cells and histamine (8 papers), Lysosomal Storage Disorders Research (3 papers) and Advanced Breast Cancer Therapies (3 papers). Holly Martin is often cited by papers focused on Mast cells and histamine (8 papers), Lysosomal Storage Disorders Research (3 papers) and Advanced Breast Cancer Therapies (3 papers). Holly Martin collaborates with scholars based in United States, Germany and United Kingdom. Holly Martin's co-authors include Richard King, Maria L. Escolar, Michele D. Poe, Joanne Kurtzberg, Ursula Goodenough, Kerstin Bergman, D A Goodenough, J. Colin Murrell, James M. Provenzale and Reuben Kapur and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Cell Biology and Blood.

In The Last Decade

Holly Martin

29 papers receiving 914 citations

Peers

Holly Martin
Louis M. Scavo United States
Ly Q. Hong‐Brown United States
M Kaplan United States
R. A. Frizzell United States
Louis M. Scavo United States
Holly Martin
Citations per year, relative to Holly Martin Holly Martin (= 1×) peers Louis M. Scavo

Countries citing papers authored by Holly Martin

Since Specialization
Citations

This map shows the geographic impact of Holly Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Martin more than expected).

Fields of papers citing papers by Holly Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Martin. The network helps show where Holly Martin may publish in the future.

Co-authorship network of co-authors of Holly Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Holly Martin. A scholar is included among the top collaborators of Holly Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly Martin. Holly Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gathirua‐Mwangi, Wambui G., Holly Martin, Dan He, et al.. (2024). Real-world outcomes in patients with brain metastases secondary to HR+/HER2− MBC treated with abemaciclib and local intracranial therapy. The Oncologist. 30(8). 1 indexed citations
2.
Martin, Holly, et al.. (2024). Patient acceptance of teleneurology across neurologic conditions. Journal of Neurology. 271(5). 2850–2858. 1 indexed citations
3.
Johnston, Stephen, Joyce O’Shaughnessy, Miguel Martín, et al.. (2021). Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups. npj Breast Cancer. 7(1). 80–80. 36 indexed citations
4.
Steele, Russell W., et al.. (2019). Drug-Resistant Salmonella typhi in Pakistan. Clinical Pediatrics. 59(1). 31–33. 10 indexed citations
5.
Kapur, Reuben, Jianjian Shi, Joydeep Ghosh, et al.. (2016). ROCK1 via LIM kinase regulates growth, maturation and actin based functions in mast cells. Oncotarget. 7(13). 16936–16947. 15 indexed citations
6.
Chatterjee, Anindya, Joydeep Ghosh, Baskar Ramdas, et al.. (2014). Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis. Cell Reports. 9(4). 1333–1348. 45 indexed citations
7.
Martin, Holly, Raghuveer Singh Mali, Peilin Ma, et al.. (2013). Pak and Rac GTPases promote oncogenic KIT–induced neoplasms. Journal of Clinical Investigation. 123(10). 4449–4463. 37 indexed citations
8.
Martin, Holly, Michele D. Poe, James M. Provenzale, et al.. (2013). Neurodevelopmental Outcomes of Umbilical Cord Blood Transplantation in Metachromatic Leukodystrophy. Biology of Blood and Marrow Transplantation. 19(4). 616–624. 80 indexed citations
9.
Ma, Ping, et al.. (2012). Role of intracellular tyrosines in activating KIT-induced myeloproliferative disease. Leukemia. 26(7). 1499–1506. 10 indexed citations
10.
Mali, Raghuveer Singh, Peilin Ma, Li‐Fan Zeng, et al.. (2012). Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT. Blood. 120(13). 2669–2678. 44 indexed citations
11.
Reuter, Sebastian, Holly Martin, Nina Dehzad, et al.. (2011). Kalanchoe pinnata inhibits mast cell activation and prevents allergic airway disease. Phytomedicine. 19(2). 115–121. 57 indexed citations
12.
White, Matthew M. & Holly Martin. (2009). Structure and Conservation of Tandem Repeats in the Mitochondrial DNA Control Region of the Least Brook Lamprey (Lampetra aepyptera). Journal of Molecular Evolution. 68(6). 715–723. 14 indexed citations
13.
Martin, Holly, et al.. (2008). Methods for assessing neurodevelopment in lysosomal storage diseases and related disorders: a multidisciplinary perspective. Acta Paediatrica. 97(s457). 69–75. 28 indexed citations
14.
Martin, Holly & Matthew M. White. (2008). Intraspecific Phylogeography of the Least Brook Lamprey (Lampetra aepyptera). Copeia. 2008(3). 579–585. 10 indexed citations
15.
Martin, Holly, et al.. (2001). Analysis of lacI mutations in Big Blue® transgenic mice subjected to parasite-induced inflammation. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 484(1-2). 69–76. 16 indexed citations
16.
Martin, Holly, et al.. (1999). How often do parenteral nutrition prescriptions for thenewborn need to be individualized?. Clinical Nutrition. 18(2). 83–85. 28 indexed citations
17.
Bellomo, Rinaldo, et al.. (1991). Continuous arteriovenous haemodiafiltration in the critically ill: Influence on major nutrient balances. Intensive Care Medicine. 17(7). 399–402. 64 indexed citations
18.
Kasper, Maren, et al.. (1988). [Detection of cytokeratin in cells of the arachnoid and in meningiomas].. PubMed. 134(3). 259–64. 3 indexed citations
19.
King, Richard & Holly Martin. (1980). Intracellular metabolism of the apoproteins of pulmonary surfactant in rat lung. Journal of Applied Physiology. 48(5). 812–820. 49 indexed citations
20.
King, Richard, et al.. (1977). Metabolism of the apoproteins in pulmonary surfactant. Journal of Applied Physiology. 42(4). 483–491. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026